July 28, 2020: Update from Managed Care Payers: COVID-19 Recovery, the Road Ahead

COVID-19
Michael Kolodziej, MD
National Medical Director
Managed Care Strategy
Flatiron Health
New York, NY
Bryan Loy, MD, MBA
Vice President, Oncology, Laboratory and Personalized Medicine
Lee N. Newcomer, MD, MHA
Principal
Lee N Newcomer Consulting
Minneapolis, MN
Steven Peskin, MD, MBA, FACP
Executive Medical Director of Population Health and Transformation, Horizon BCBS
Michael Sherman, MD, MBA, MS
Senior Vice President & Chief Medical Officer
Harvard Pilgrim Healthcare
Burt Zweigenhaft, PhD, D.Litt
Editor-in-Chief, VBCC;
Executive Vice President, FFF Enterprises;
Executive Director and Co-Founder, Association for Value-Based Cancer Care
One of the most significant questions for payers in the COVID-19 health ecosystem is, “Will reimbursement parity for telehealth services continue?” Leading representatives of major managed care organizations debate the prospects.

Related Articles

mRNA COVID-19 Vaccine Appears Safe and Effective in Patients with Cancer Receiving Active Treatment
By Chase Doyle
COVID-19
February 2022, Vol 13, No 1 Online Only
Read Article
Current and Future Effects of the COVID-19 Pandemic on Cancer Care
By Phoebe Starr
COVID-19
June 2021, Vol 12, No 3
Read Article
Later Diagnoses, Worse Outcomes in Patients with Lung Cancer During COVID-19 May Last
By Walter Alexander
COVID-19, Lung Cancer
April 2021, Vol 12, No 2
Read Article
Patients with Lung Cancer Distressed About Impact of COVID-19 on Access to Care
By Walter Alexander
COVID-19
April 2021, Vol 12, No 2
Read Article
AVBCC Celebrates World Cancer Day
By Burt Zweigenhaft, PhD, D.Litt
Videos
Read Article
Managing Cholangiocarcinoma in the Setting of COVID-19: Unique Challenges and Opportunities
By Ghassan K. Abou-Alfa, MD, MBA; Bruce Lin, MD; Farshid Dayyani, MD, PhD; Richard Kim, MD; Rachna T. Shroff, MD, MS; Melinda Bachini; Milind M. Javle, MD
Cholangiocarcinoma, COVID-19
December 2020, Special Issue: Managing CCA in the Setting of COVID-19
Read Article
COVID-Related Death Rate Tripled in Patients with Cancer versus the General Population
By Phoebe Starr
AACR COVID-19 Highlights, COVID-19
October 2020, Vol 11, No 5
Read Article
Comprehensive Cancer Centers and Integrated Delivery Networks
COVID-19
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article
How COVID-19 Is Affecting Patient Advocacy Groups: Financial Need Increasing
COVID-19
August 2020, Vol 11, Special Issue: Payers' Perspectives in Oncology
Read Article

Stay In The Know

Stay up to date on the matters of value in cancer by signing up for the free, bi-monthly VBCC print publication and VBCC weekly e‑newsletter.

Subscribe
Amplity
© Amplity, Inc. All Rights Reserved. Privacy Policy.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?